MyFinsight
Home
Blog
About
Back
Income Statement
Ernexa Therapeutics Inc. (ERNA)
Ernexa Therapeutics Inc. (ERNA)
source: myfinsight.com
Net loss
attributable to common...
-$4,017K
(-27.65%↓ Y/Y)
Net loss
-$4,009K
(-27.72%↓ Y/Y)
Series a preferred
stock dividend
$8K
(0.00%↑ Y/Y)
Interest income
(expense), net
$55K
Loss on
extinguishment of contingent...
$41K
Loss before income
taxes
-$4,009K
(-27.84%↓ Y/Y)
Total other income
(expense), net
$95K
(114.96%↑ Y/Y)
Other expense, net
-$1K
(99.19%↑ Y/Y)
Loss from operations
-$4,104K
(-64.09%↓ Y/Y)
Total operating
expenses
$4,104K
(64.09%↑ Y/Y)
Research and development
$2,792K
(145.77%↑ Y/Y)
General and
administrative
$1,312K
(-3.88%↓ Y/Y)
Back